Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4797927
Max Phase: Preclinical
Molecular Formula: C44H60N4O11
Molecular Weight: 820.98
Molecule Type: Unknown
Associated Items:
ID: ALA4797927
Max Phase: Preclinical
Molecular Formula: C44H60N4O11
Molecular Weight: 820.98
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc2c(CC(=O)N[C@@H](CC(=O)O)C(=O)O[C@@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@@H]([C@H](C)CCC(=O)OCCOCCN=[N+]=[N-])CC[C@@H]54)C3)cc(=O)oc2c1
Standard InChI: InChI=1S/C44H60N4O11/c1-26(5-12-40(52)57-20-19-56-18-17-46-48-45)33-10-11-34-32-8-6-28-23-30(13-15-43(28,2)35(32)14-16-44(33,34)3)58-42(54)36(25-39(50)51)47-38(49)21-27-22-41(53)59-37-24-29(55-4)7-9-31(27)37/h7,9,22,24,26,28,30,32-36H,5-6,8,10-21,23,25H2,1-4H3,(H,47,49)(H,50,51)/t26-,28-,30-,32+,33-,34+,35+,36+,43+,44-/m1/s1
Standard InChI Key: PEVIPXNFOUCRDZ-VFVZIWHOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 820.98 | Molecular Weight (Monoisotopic): 820.4259 | AlogP: 7.16 | #Rotatable Bonds: 18 |
Polar Surface Area: 216.43 | Molecular Species: ACID | HBA: 11 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -10.22 | CX Basic pKa: | CX LogP: 5.79 | CX LogD: 2.38 |
Aromatic Rings: 2 | Heavy Atoms: 59 | QED Weighted: 0.04 | Np Likeness Score: 0.91 |
1. Fu CW,Tsai HE,Chen WS,Chang TT,Chen CL,Hsiao PW,Li WS. (2021) Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis., 64 (1.0): [PMID:33371679] [10.1021/acs.jmedchem.0c01477] |
Source(1):